Given that TrxR1 is often overexpressed in many cancer cells and targeting its ablation leads to a reduction in tumor progression and metastasis, this selenoenzyme is highlighted as a potential target for cancer therapy via regulating redox balance in cancer cells [16, 17]. The gene discussed is TXNRD1; the disease is neoplasm.